Advanz Pharma Services (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 25 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 20.56%
- Profit Growth 20.89%
- Ebitda 38.94%
- Net Worth 22.20%
- Total Assets 28.56%
About Advanz Pharma Services (India)
Advanz Pharma Services (India) Private Limited (APSIPL) is a leading Private Limited Foreign Company Incorporated In India incorporated in India on 18 June 1999 and has a history of 25 years and seven months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Concordia International (India) Private Limited. The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bhavesh Godhania, Abhishek Sinha, and Gaurav Wadhwa serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74990MH1999FTC120396
- Company No.
120396
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
18 Jun 1999
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Advanz Pharma Services (India)?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Wadhwa  | Director | 22-Mar-2022 | Current |
Bhavesh Godhania  | Director | 30-Sep-2013 | Current |
| Abhishek Sinha | Director | 23-Feb-2022 | Current |
Financial Performance of Advanz Pharma Services (India).
Advanz Pharma Services (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.56% increase. The company also saw a substantial improvement in profitability, with a 20.89% increase in profit. The company's net worth Soared by an impressive increase of 22.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Advanz Pharma Services (India)?
In 2023, Advanz Pharma Services (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Advanz Pharma Services (India)?
Advanz Pharma Services (India) has a workforce of 264 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advanz Pharma Services (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advanz Pharma Services (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
